BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Gem Pharmaceuticals Receives U.S. Orphan Drug Designation For GPX-150 In The Treatment Of Patients With Sarcoma

  January 6, 2016

   · 

  2 min read
• Drug Development

  DURECT Corporation Announces Positive Phase 1 Data For DUR-928

  January 6, 2016

   · 

  5 min read
• Drug Development

  eFFECTOR Initiates Dosing In Phase 1/2 Clinical Trial Of eFT508 In Solid Tumors

  January 6, 2016

   · 

  3 min read
• Deals

  Omnicell Completes Acquisition Of Aesynt

  January 6, 2016

   · 

  7 min read
• Business

  RDD Pharma Appoints Michael Rice To Board Of Directors

  January 6, 2016

   · 

  2 min read
• Drug Development

  Glide Technologies Announces Successful Proof-Of-Concept With Novel Exenatide Solid Dose Formulation

  January 6, 2016

   · 

  2 min read
• Business

  Beyondspring Pharmaceuticals And Fred Hutchinson Cancer Research Center Enter Collaboration Agreement

  January 6, 2016

   · 

  5 min read
• Biotech Beach

  A Letter From the ChromaDex, Inc. Chief Executive Officer

  January 6, 2016

   · 

  10 min read
• Drug Development

  Recro Pharma Reports Positive Top-Line Results For Phase II Clinical Trial Of IV Meloxicam

  January 6, 2016

   · 

  6 min read
• FDA

  MEDTECH Receives FDA Clearance for ROSA Spine

  January 6, 2016

   · 

  2 min read